Singapore markets closed

RNA Jun 2024 29.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.0500-0.1500 (-75.00%)
As of 03:40PM EDT. Market open.
Full screen
Previous close0.2000
Open0.0500
Bid0.0000
Ask0.0500
Strike29.00
Expiry date2024-06-21
Day's range0.0500 - 0.0500
Contract rangeN/A
Volume1
Open interest16
  • PR Newswire

    Avidity Biosciences to Participate in Upcoming Investor Conference

    Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that Avidity management will be participating at the following upcoming conference:

  • PR Newswire

    Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock

    Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced the pricing of an underwritten public offering of 10,550,000 shares of its common stock at a price to the public of $38.00 per share. All of the shares to be sold in the offering are to be sold by Avidity. The gross proceeds to Avidity from the offering, before deducting the underwriting discounts and comm

  • Zacks

    Avidity (RNA) Up 33% on Rare Muscle Disease Study Results

    Initial data from an early-stage study shows that treatment with Avidity's (RNA) experimental therapy could address the underlying cause of a rare muscle-weakening condition.